Company Filing History:
Years Active: 2012
Title: Inventor Ulrike Eisenmann: Pioneering Research in Branching Morphogenesis
Introduction
Ulrike Eisenmann, based in Tutzing, Germany, is a notable inventor with significant contributions to the field of medical science. With one patent to her name, her work primarily focuses on the modulation of branching morphogenesis, an essential process in biological development.
Latest Patents
Eisenmann's patent, titled "Mylks as Modifiers of Branching Morphogenesis and Methods of Use," identifies human MYLK genes as crucial modulators of branching morphogenesis. This innovation provides a framework for therapeutic interventions in disorders linked to defective branching morphogenesis functions. The patent outlines methods for identifying agents that can modulate MYLK activity, paving the way for potential medical applications.
Career Highlights
Eisenmann is currently associated with Exelixis, Inc., a biotechnology company known for its focus on discovering and developing small molecule therapies for cancer. Her role involves collaborating with various experts in the field to advance the understanding and therapies related to developmental biology.
Collaborations
Throughout her career, Eisenmann has worked alongside esteemed colleagues, including Gregory D. Plowman and Felix D. Karim. This collaborative environment reinforces the importance of teamwork in scientific research and innovation, significantly enhancing the impact of her work on branching morphogenesis.
Conclusion
Ulrike Eisenmann stands out as an influential innovator whose contributions to the field of branching morphogenesis hold promise for new therapeutic strategies. Her patent reflects her commitment to advancing medical science, and her collaborations showcase the significance of partnership in achieving groundbreaking research.